Bank of America’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-2,860
| Closed | -$1K | – | 7535 |
|
|
2018
Q1 | $1K | Sell |
2,860
-875
| -23% | -$1.31K | ﹤0.01% | 7044 |
|
|
2017
Q4 | $7K | Buy |
3,735
+820
| +28% | +$1.41K | ﹤0.01% | 6693 |
|
|
2017
Q3 | $4K | Sell |
2,915
-2,932
| -50% | -$4.17K | ﹤0.01% | 6795 |
|
|
2017
Q2 | $10K | Buy |
5,847
+1,259
| +27% | +$2.82K | ﹤0.01% | 6434 |
|
|
2017
Q1 | $15K | Buy |
4,588
+821
| +22% | +$3.88K | ﹤0.01% | 6432 |
|
|
2016
Q4 | $19K | Buy |
3,767
+735
| +24% | +$12.7K | ﹤0.01% | 6372 |
|
|
2016
Q3 | $76K | Sell |
3,032
-289
| -9% | -$7.29K | ﹤0.01% | 5557 |
|
|
2016
Q2 | $83K | Buy |
3,321
+3,196
| +2,557% | +$90.3K | ﹤0.01% | 5620 |
|
|
2016
Q1 | $4K | Sell |
125
-1,233
| -91% | -$33.5K | ﹤0.01% | 6669 |
|
|
2015
Q4 | $50K | Buy |
1,358
+715
| +111% | +$31.6K | ﹤0.01% | 6046 |
|
|
2015
Q3 | $31K | Buy |
643
+520
| +423% | +$36.3K | ﹤0.01% | 6157 |
|
|
2015
Q2 | $8K | Buy |
+123
| New | +$5.69K | ﹤0.01% | 6679 |
|
|
2014
Q4 | – | Sell |
-12,500
| Closed | -$192K | – | 8161 |
|
|
2014
Q3 | $192K | Buy |
+12,500
| New | +$263K | ﹤0.01% | 5423 |
|
|
2014
Q1 | – | Sell |
-61
| Closed | -$2K | – | 8304 |
|
|
2013
Q4 | $2K | Sell |
61
-95
| -61% | -$2.45K | ﹤0.01% | 7666 |
|
|
2013
Q3 | $5K | Sell |
156
-31
| -17% | -$961 | ﹤0.01% | 7414 |
|
|
2013
Q2 | $6K | Buy |
+187
| New | +$6.98K | ﹤0.01% | 7325 |
|
Other funds holding ANTH
Bank of America's ANTH Position: Q2 2018 in Review
Bank of America sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2018, closing a stake of 2,860 shares — an estimated $1K sold.
Bank of America first reported a position in ANTH in Q2 2013 and held it in 16 quarters. The position peaked at $192K in Q3 2014. 5 funds tracked by Wall St. Rank hold ANTH as of Q2 2018.
- Bank of America reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
- Bank of America sold 2,860 Anthera Pharmaceuticals, Inc. shares in Q2 2018, an estimated $1K.
- Bank of America first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2013 and held it in 16 quarters.
- Bank of America's Anthera Pharmaceuticals, Inc. position peaked at $192K in Q3 2014.
- 5 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2018.
Based on Bank of America's 13F filing for Q2 2018, filed 14 Aug 2018.